Screening for esophageal involvement in morphea: Is it needed?

Tasleem Arif

Full Text:



Arif T, Adil M, Amin SS, Tahseen M, Dorjay K, Mohtashim M et al. Clinico-epidemiological Study of Morphea from a Tertiary Care Hospital. Curr Rheumatol Rev. 2018;14:251-4..

Arif T, Massod Q, Singh J, Hassan I. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study. BMC Gastroenterol. 2015;15:24.

Zaninotto G, Peserico A, Costantini M, Salvador L, Rondinone R. Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma. Scand J Gastroenterol. 1989;24:95-102.

Weihrauch TR, Korting GW. Manometric assessment of esophageal involvement in progressive systemic sclerosis, morphoea and Raynaud’s disease. Br J Dermatol. 1982;107:325-32.

Dehen L, Roujeau JC, Cosnes A, Revuz J. Internal involvement in localized scleroderma. Medicine. 1994;73:241-5.

Callen JP. Esophageal Involvement Is Not Seen in Patients with Morphea (Localized Scleroderma). NEJM Journal Watch. September 29, 2015. Available at

Guariso G, Conte S, Galeazzi F, Vettorato MG, Martini G, Zulian F. Esophageal involvement in juvenile localized scleroderma: a pilot study. Clin Exp Rheumatol. 2007;25:786-9.

Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873-81.


  • There are currently no refbacks.

ISSN: 1560-9014